PAF and EZH2 induce wnt/β-catenin signaling hyperactivation

Molecular Cell

Volumn 52, Issue 2, 2013, Pages 193-205

  Jung, Hae Yun ^a   Jun, Sohee ^a   Lee, Moonsup ^a   Kim, Han Cheon ^a   Wang, Xin ^a   Ji, Hong ^a   McCrea, Pierre D ^a,b   Park, Jae Il ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLINE; DNA; DOXYCYCLINE; METHYLTRANSFERASE; THROMBOCYTE ACTIVATING FACTOR; TRANSCRIPTION FACTOR EZH2; WNT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL PROLIFERATION; COLON ADENOCARCINOMA; COLON CANCER; CONTROLLED STUDY; DISSOCIATION; DNA SYNTHESIS; EMBRYO; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE CANCER; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROCESSING; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION INITIATION; TUMOR XENOGRAFT; XENOPUS LAEVIS;

ANIMALS; BETA CATENIN; CARRIER PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; COLONIC NEOPLASMS; EMBRYO, MAMMALIAN; EMBRYO, NONMAMMALIAN; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HCT116 CELLS; HEK293 CELLS; HT29 CELLS; HUMANS; IMMUNOBLOTTING; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; POLYCOMB REPRESSIVE COMPLEX 2; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WNT SIGNALING PATHWAY; XENOPUS LAEVIS;

MUS; XENOPUS LAEVIS;

EID: 84886310917     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2013.08.028     Document Type: Article

References (43)

1. Ahn K., Mishina Y., Hanks M.C., Behringer R.R., Crenshaw E.B. BMPR-IA signaling is required for the formation of the apical ectodermal ridge and dorsal-ventral patterning of the limb. Development 2001, 128:4449-4461.
2. Amrani Y.M., Gill J., Matevossian A., Alonzo E.S., Yang C., Shieh J.H., Moore M.A., Park C.Y., Sant'Angelo D.B., Denzin L.K. The Paf oncogene is essential for hematopoietic stem cell function and development. J.Exp. Med. 2011, 208:1757-1765.
3. Barker N., Ridgway R.A., van Es J.H., van de Wetering M., Begthel H., van den Born M., Danenberg E., Clarke A.R., Sansom O.J., Clevers H. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009, 457:608-611.
4. Beachy P.A., Karhadkar S.S., Berman D.M. Tissue repair and stem cell renewal in carcinogenesis. Nature 2004, 432:324-331.
5. Carrera I., Janody F., Leeds N., Duveau F., Treisman J.E. Pygopus activates Wingless target gene transcription through the mediator complex subunits Med12 and Med13. Proc. Natl. Acad. Sci. USA 2008, 105:6644-6649.
6. Chang C.J., Yang J.Y., Xia W., Chen C.T., Xie X., Chao C.H., Woodward W.A., Hsu J.M., Hortobagyi G.N., Hung M.C. EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signaling. Cancer Cell 2011, 19:86-100.
7. Cheng A.S., Lau S.S., Chen Y., Kondo Y., Li M.S., Feng H., Ching A.K., Cheung K.F., Wong H.K., Tong J.H., et al. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis. Cancer Res. 2011, 71:4028-4039.
8. Clevers H., Nusse R. Wnt/β-catenin signaling and disease. Cell 2012, 149:1192-1205.
9. Deka J., Wiedemann N., Anderle P., Murphy-Seiler F., Bultinck J., Eyckerman S., Stehle J.C., André S., Vilain N., Zilian O., et al. Bcl9/Bcl9l are critical for Wnt-mediated regulation of stem cell traits in colon epithelium and adenocarcinomas. Cancer Res. 2010, 70:6619-6628.
10. Derks S., Bosch L.J., Niessen H.E., Moerkerk P.T., van den Bosch S.M., Carvalho B., Mongera S., Voncken J.W., Meijer G.A., de Bruïne A.P., et al. Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21. Carcinogenesis 2009, 30:1041-1048.
11. Emanuele M.J., Ciccia A., Elia A.E., Elledge S.J. Proliferating cell nuclear antigen (PCNA)-associated KIAA0101/PAF15 protein is a cell cycle-regulated anaphase-promoting complex/cyclosome substrate. Proc. Natl. Acad. Sci. USA 2011, 108:9845-9850.
12. Funayama N., Fagotto F., McCrea P., Gumbiner B.M. Embryonic axis induction by the armadillo repeat domain of beta-catenin: evidence for intracellular signaling. J. Cell Biol. 1995, 128:959-968.
13. Fussbroich B., Wagener N., Macher-Goeppinger S., Benner A., Fälth M., Sültmann H., Holzer A., Hoppe-Seyler K., Hoppe-Seyler F. EZH2 depletion blocks the proliferation of colon cancer cells. PLoS ONE 2011, 6:e21651.
14. Goentoro L., Kirschner M.W. Evidence that fold-change, and not absolute level, of beta-catenin dictates Wnt signaling. Mol. Cell 2009, 36:872-884.
15. He B., Reguart N., You L., Mazieres J., Xu Z., Lee A.Y., Mikami I., McCormick F., Jablons D.M. Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations. Oncogene 2005, 24:3054-3058.
16. He T.C., Sparks A.B., Rago C., Hermeking H., Zawel L., da Costa L.T., Morin P.J., Vogelstein B., Kinzler K.W. Identification of c-MYC as a target of the APC pathway. Science 1998, 281:1509-1512.
17. Imbert A., Eelkema R., Jordan S., Feiner H., Cowin P. Delta N89 beta-catenin induces precocious development, differentiation, and neoplasia in mammary gland. J. Cell Biol. 2001, 153:555-568.
18. Jho E.H., Zhang T., Domon C., Joo C.K., Freund J.N., Costantini F. Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol. Cell. Biol. 2002, 22:1172-1183.
19. Joshi P., Carrington E.A., Wang L., Ketel C.S., Miller E.L., Jones R.S., Simon J.A. Dominant alleles identify SET domain residues required for histone methyltransferase of Polycomb repressive complex 2. J.Biol. Chem. 2008, 283:27757-27766.
20. Jung H.Y., Wang X., Jun S., Park J.I. Dyrk2-associated EDD-DDB1-VprBP E3 ligase inhibits telomerase by TERT degradation. J.Biol. Chem. 2013, 288:7252-7262.
21. Kengaku M., Capdevila J., Rodriguez-Esteban C., De La Peña J., Johnson R.L., Izpisúa Belmonte J.C., Tabin C.J. Distinct WNT pathways regulating AER formation and dorsoventral polarity in the chick limb bud. Science 1998, 280:1274-1277.
22. Kim K.A., Kakitani M., Zhao J., Oshima T., Tang T., Binnerts M., Liu Y., Boyle B., Park E., Emtage P., et al. Mitogenic influence of human R-spondin1 on the intestinal epithelium. Science 2005, 309:1256-1259.
23. Kondo Y., Shen L., Cheng A.S., Ahmed S., Boumber Y., Charo C., Yamochi T., Urano T., Furukawa K., Kwabi-Addo B., et al. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat. Genet. 2008, 40:741-750.
24. Kuzmichev A., Margueron R., Vaquero A., Preissner T.S., Scher M., Kirmizis A., Ouyang X., Brockdorff N., Abate-Shen C., Farnham P., Reinberg D. Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation. Proc. Natl. Acad. Sci. USA 2005, 102:1859-1864.
25. Li X., Gonzalez M.E., Toy K., Filzen T., Merajver S.D., Kleer C.G. Targeted overexpression of EZH2 in the mammary gland disrupts ductal morphogenesis and causes epithelial hyperplasia. Am. J. Pathol. 2009, 175:1246-1254.
26. Lustig B., Jerchow B., Sachs M., Weiler S., Pietsch T., Karsten U., van de Wetering M., Clevers H., Schlag P.M., Birchmeier W., Behrens J. Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol. Cell. Biol. 2002, 22:1184-1193.
27. Moser A.R., Pitot H.C., Dove W.F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 1990, 247:322-324.
28. Park J.I., Venteicher A.S., Hong J.Y., Choi J., Jun S., Shkreli M., Chang W., Meng Z., Cheung P., Ji H., et al. Telomerase modulates Wnt signalling by association with target gene chromatin. Nature 2009, 460:66-72.
29. Polakis P. The many ways of Wnt in cancer. Curr. Opin. Genet. Dev. 2007, 17:45-51.
30. Povlsen L.K., Beli P., Wagner S.A., Poulsen S.L., Sylvestersen K.B., Poulsen J.W., Nielsen M.L., Bekker-Jensen S., Mailand N., Choudhary C. Systems-wide analysis of ubiquitylation dynamics reveals a key role for PAF15 ubiquitylation in DNA-damage bypass. Nat. Cell Biol. 2012, 14:1089-1098.
31. Sage J., Miller A.L., Pérez-Mancera P.A., Wysocki J.M., Jacks T. Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature 2003, 424:223-228.
32. Sale J.E., Lehmann A.R., Woodgate R. Y-family DNA polymerases and their role in tolerance of cellular DNA damage. Nat. Rev. Mol. Cell Biol. 2012, 13:141-152.
33. Sangiorgi E., Capecchi M.R. Bmi1 is expressed invivo in intestinal stem cells. Nat. Genet. 2008, 40:915-920.
34. Schwab K.R., Patterson L.T., Hartman H.A., Song N., Lang R.A., Lin X., Potter S.S. Pygo1 and Pygo2 roles in Wnt signaling in mammalian kidney development. BMC Biol. 2007, 5:15.
35. Shi B., Liang J., Yang X., Wang Y., Zhao Y., Wu H., Sun L., Zhang Y., Chen Y., Li R., et al. Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells. Mol. Cell. Biol. 2007, 27:5105-5119.
36. Sparmann A., van Lohuizen M. Polycomb silencers control cell fate, development and cancer. Nat. Rev. Cancer 2006, 6:846-856.
37. Suzuki H., Watkins D.N., Jair K.W., Schuebel K.E., Markowitz S.D., Chen W.D., Pretlow T.P., Yang B., Akiyama Y., Van Engeland M., et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat. Genet. 2004, 36:417-422.
38. Tetsu O., McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999, 398:422-426.
39. Vermeulen L., De Sousa E Melo F., van der Heijden M., Cameron K., de Jong J.H., Borovski T., Tuynman J.B., Todaro M., Merz C., Rodermond H., et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat. Cell Biol. 2010, 12:468-476.
40. Wyngaarden L.A., Delgado-Olguin P., Su I.H., Bruneau B.G., Hopyan S. Ezh2 regulates anteroposterior axis specification and proximodistal axis elongation in the developing limb. Development 2011, 138:3759-3767.
41. Xu K., Wu Z.J., Groner A.C., He H.H., Cai C., Lis R.T., Wu X., Stack E.C., Loda M., Liu T., et al. EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent. Science 2012, 338:1465-1469.
42. Yu P., Huang B., Shen M., Lau C., Chan E., Michel J., Xiong Y., Payan D.G., Luo Y. p15(PAF), a novel PCNA associated factor with increased expression in tumor tissues. Oncogene 2001, 20:484-489.
43. Zhang S., Cagatay T., Amanai M., Zhang M., Kline J., Castrillon D.H., Ashfaq R., Oz O.K., Wharton K.A. Viable mice with compound mutations in the Wnt/Dvl pathway antagonists nkd1 and nkd2. Mol. Cell. Biol. 2007, 27:4454-4464.